<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1346">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04509973</url>
  </required_header>
  <id_info>
    <org_study_id>RH-ITA-009</org_study_id>
    <secondary_id>2020-003363-25</secondary_id>
    <secondary_id>2020-07-16</secondary_id>
    <secondary_id>H-20051056</secondary_id>
    <nct_id>NCT04509973</nct_id>
  </id_info>
  <brief_title>Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia</brief_title>
  <acronym>COVIDSTEROID2</acronym>
  <official_title>Higher vs. Lower Doses of Dexamethasone in Patients With COVID-19 and Severe Hypoxia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scandinavian Critical Care Trials Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Copenhagen Trial Unit, Center for Clinical Intervention Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre for Research in Intensive Care (CRIC)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The George Institute for Global Health, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Scandinavian Critical Care Trials Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to assess the benefits and harms of higher (12 mg) vs lower doses (6 mg) of
      dexamethasone on patient-centered outcomes in patients with COVID-19 and severe hypoxia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Preliminary results from the Randomised Evaluation of COVid-19 thERapY (RECOVERY)
      trial have reported a reduction in 28-day mortality with low-dose dexamethasone (6 mg) once
      daily versus no intervention in hospitalised patients with COVID-19; an effect that may have
      been more pronounced in patients with increasing hypoxia. Yet, higher doses of dexamethasone
      may be beneficial in patients with non-COVID-19 acute respiratory distress syndrome. At
      present, it is unclear what dose of dexamethasone is most beneficial in patients with
      COVID-19 and severe hypoxia, and clinical equipoise exists.

      Objective: We aim to assess the effects of higher (12 mg) vs lower doses (6 mg) of
      intravenous dexamethasone on the number of days alive without life-support in adult patients
      with COVID-19 and severe hypoxia.

      Design: International, parallel-group, centrally randomised, stratified, blinded, clinical
      trial.

      Population: Adult patients with documented COVID-19 receiving at least 10 L/min of oxygen
      independent of delivery system OR mechanical ventilation.

      Experimental intervention: Dexamethasone 12 mg once daily for up to 10 days in addition to
      standard care.

      Control intervention: Dexamethasone 6 mg once daily for up to 10 days in addition to standard
      care.

      Outcomes: The primary outcome is days alive without life support (i.e. mechanical
      ventilation, circulatory support, or renal replacement therapy) at day 28. Secondary outcomes
      are serious adverse reactions (i.e. anaphylactic reaction to hydrocortisone, new episode of
      septic shock, invasive fungal infection or clinically important gastrointestinal bleeding) at
      day 28; days alive without life support at day 90; days alive and out of hospital at day 90;
      all-cause mortality at day 28, 90 and 180; and health-related quality of life at day 180.

      Sample size: A total of 1000 participants will be randomised in order to detect a 15%
      relative reduction in 28-day mortality combined with a 10% reduction in time on life support
      among the survivors with a power of 85%.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 27, 2020</start_date>
  <completion_date type="Anticipated">February 17, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 17, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Days alive without life support at day 28</measure>
    <time_frame>Day 28 after randomisation</time_frame>
    <description>Days alive without life support (i.e. invasive mechanical ventilation, circulatory support or renal replacement therapy) from randomisation to day 28</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with one or more serious adverse reactions</measure>
    <time_frame>Day 28 after randomisation</time_frame>
    <description>Serious adverse reactions defined as new episodes of septic shock, invasive fungal infection, clinically important gastrointestinal bleeding or anaphylactic reaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality at day 28</measure>
    <time_frame>Day 28 after randomisation</time_frame>
    <description>Death from all causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality at day 90</measure>
    <time_frame>Day 90 after randomisation</time_frame>
    <description>Death from all causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days alive without life support at day 90</measure>
    <time_frame>Day 90 after randomisation</time_frame>
    <description>Days alive without life support (i.e. invasive mechanical ventilation, circulatory support or renal replacement therapy) from randomisation to day 90</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days alive and out of hospital at day 90</measure>
    <time_frame>Day 90 after randomisation</time_frame>
    <description>Number of days alive and out of hospital not limited to the index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality at day 180</measure>
    <time_frame>Day 180 after randomisation</time_frame>
    <description>Death from all causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life at day 180</measure>
    <time_frame>Day 180 after randomisation</time_frame>
    <description>Assessed by EQ-5D-5L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life at day 180</measure>
    <time_frame>Day 180 after randomisation</time_frame>
    <description>Assessed by EQ-VAS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Covid19</condition>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>Dexamethasone 12 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous bolus injection of dexamethasone 12 mg once daily in addition to standard care for up to 10 days. We will allow the use of betamethasone 12 mg at sites, where dexamethasone is not available.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 6 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous bolus injection of dexamethasone 6 mg once daily in addition to standard care for up to 10 days. We will allow the use of betamethasone 6 mg at sites, where dexamethasone is not available.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>ATC code: H02AB02</description>
    <arm_group_label>Dexamethasone 12 mg</arm_group_label>
    <arm_group_label>Dexamethasone 6 mg</arm_group_label>
    <other_name>Dexavit</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: All of the following must be fulfilled

          -  Aged 18 years or above AND

          -  Confirmed SARS-CoV-2 (COVID-19) requiring hospitalisation AND

          -  Use of one of the following:

               -  Invasive mechanical ventilation OR

               -  Non-invasive ventilation or continuous use of continuous positive airway pressure
                  (CPAP) for hypoxia OR

               -  Oxygen supplementation with an oxygen flow of at least 10 L/min independent of
                  delivery system

        Exclusion Criteria: We will exclude patients who fulfil any of the following criteria:

          -  Use of systemic corticosteroids for other indications than COVID-19 in doses higher
             than 6 mg dexamethasone equivalents

          -  Use of systemic corticosteroids for COVID-19 for 5 days consecutive days or more

          -  Invasive fungal infection

          -  Active tuberculosis

          -  Fertile woman (&lt;60 years of age) with positive urine human gonadotropin (hCG) or
             plasma-hCG

          -  Known hypersensitivity to dexamethasone

          -  Previously randomised into the COVID STEROID 2 trial

          -  Informed consent not obtainable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anders Perner, MD, PhD, Professor</last_name>
    <phone>+4535458333</phone>
    <email>anders.perner@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Warrer Petersen, MD</last_name>
    <phone>+4535457236</phone>
    <email>marie.warrer.petersen.01@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Aalborg University Hospital, Denmark.</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bodil S Rasmussen, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive care, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steffen Christensen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders Perner, MD PhD</last_name>
      <phone>+4535458333</phone>
      <email>anders.perner@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Marie Warrer B Petersen, MD</last_name>
      <phone>+4535457237</phone>
      <email>marie.warrer.petersen.01@regionh.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dept. of Neuroanaesthesiology</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margit Smitt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Thoracic Anaesthesiology, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vibeke RL Jørgensen, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept of Infectious diseases, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie Helleberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Gentofte Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Mohr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne Sofie Andreasen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia, Regional Hospital West Jutland, Herning</name>
      <address>
        <city>Herning</city>
        <zip>7400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Iben S Darfelt</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Nordsjællands Hospital - Hillerød, Denmark.</name>
      <address>
        <city>Hillerød</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Morten Bestle, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hvidovre Hospital - Dept of Infectious diseases</name>
      <address>
        <city>Hvidovre</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Benfield</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hvidovre Hospital - Dept of Intensive Care</name>
      <address>
        <city>Hvidovre</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Klaus T Kristiansen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hvidovre Hospital - Dept of Pulmonary Medicine</name>
      <address>
        <city>Hvidovre</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charlotte S Ulrik</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Lillebaelt Hospital</name>
      <address>
        <city>Kolding</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne C Brøchner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care, Køge University Hospital</name>
      <address>
        <city>Køge</city>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lone M Poulsen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept of Intensive Care, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Strøm</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Zealand University Hospital Roskilde</name>
      <address>
        <city>Roskilde</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Hildebrandt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia, Slagelse Hospital</name>
      <address>
        <city>Slagelse</city>
        <zip>4200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anders Møller</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Viborg Hospital</name>
      <address>
        <city>Viborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christoffer Sølling, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jawahar Lal Nehru Medical Collega, AMU</name>
      <address>
        <city>Aligarh</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Syed M Ahmed</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Apollo Hospital</name>
      <address>
        <city>Chennai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bharath KT Vijayaraghavan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amrita Institute of Medical Sciences</name>
      <address>
        <city>Kochi</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zubair U Mohamed</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bombay Hospital &amp; Medical Research Centre</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pravin Amin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>K. J. Somaiya Super Specialty Hospital</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amit Shobhavat</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>P. D. Hinduja National Hospital &amp; Medical Research Centre</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Farhad Kapadia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>S L Raheja Fortis Hospital</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sanjith Saseedharan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tata Memorial Hospital</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>J V Divatia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wockhardt hospitals</name>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kedar Toraskar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indraprastha Apollo Hospital</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rajesh Chawla</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Max Super Specialty Hospital, Saket</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Omender Singh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Symbiosis University Hospital and Research Centre</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Urvi Shukla</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vishwaraj Hospital</name>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kapil Boraoke</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rajendra Institute of Medical Sciences</name>
      <address>
        <city>Ranchi</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Saif M Khan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gotri General Hospital</name>
      <address>
        <city>Vadodara</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Neeta B Nayak</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christian Medical College Vellore</name>
      <address>
        <city>Vellore</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Binila Chacko</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Sahlgranska Universitetssjukhuset</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathan Oras</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Infectious Diseases, Sahlgranska Universitetssjukhuset</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Magnus Gisslen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Universitetssjukhuset i Linköping</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michelle Chew</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Skånes Universitetssjukhus (SUS) Malmö</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fredrik Sjövall</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Infectious Diseases, Skånes Universitetssjukhus (SUS) Malmö</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna Nilsson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Vrinnevisjukhuset, Norrköping</name>
      <address>
        <city>Norrköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fredrik Schiöler</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Capio St Görans Sjukhus</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas Wiklund</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Danderyds Sjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olof Wall</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Karolinska Universitetssjukhuset, Huddinge</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Åke Norberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Anaesthesia and Intensive Care, Karolinska Universitetssjukhuset, Solna</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johan Mårtensson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Cardiology, Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacob Hollenberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Infectious Diseases, Danderyds Sjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Magnus Hedenstierna</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Infectious Diseases, Karolinska Universitetssjukhuset, Solna</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pontus Naucler</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Infectious Diseases, Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carl-Johan Treutiger</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Internal Medicine, Danderyds Sjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sara Tehrani</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept. of Internal Medicine, Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Buster Mannheimer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Cronhjort</last_name>
    </contact>
    <contact_backup>
      <last_name>Rebecka R Wahlin</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dept. of Intensive Care Medicine, Bern University Hospital (Inselspital)</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephan M Jakob</last_name>
    </contact>
    <contact_backup>
      <last_name>Luca Cioccari</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>India</country>
    <country>Sweden</country>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.cric.nu/covid-steroid-2/</url>
    <description>Trial website</description>
  </link>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2020</study_first_posted>
  <last_update_submitted>August 28, 2020</last_update_submitted>
  <last_update_submitted_qc>August 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Randomised clinical trial</keyword>
  <keyword>COVID-19</keyword>
  <keyword>Hypoxia</keyword>
  <keyword>Corticosteroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Fully de-identified IPD will be shared after the approval by the the trial management committee</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Immediate sharing of protocol, SAP and ICF. CSR will be shared no later than 6 months after last-patient-last-visit</ipd_time_frame>
    <ipd_access_criteria>Contact to the trial management committee</ipd_access_criteria>
    <ipd_url>http://www.cric.nu/covid-steroid-2/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

